Close Menu

GPR39 as a Therapeutic Target in Vascular Cognitive Impairment Dementia

Oct
27
9:00 am to 10:00 am
Dr. Nabil Alkayed

Please join Dr. Nabil Alkayed, Professor of Anesthesiology & Perioperative Medicine, Neurology, Neurological Surgery, Cardiovascular Medicine and Physiology & Pharmacology at Oregon Health & Science University (OHSU) for a presentation over breakfast.  

Dr. Alkayed’s presentation will review human and experimental evidence for the role of eicosanoid signaling in aging-related cognitive impairment and dementia (VCID), specifically focusing on the role of P450 eicosanoids and the newly discovered G protein-coupled receptor 39 (GPR39). Evidence supporting the role of GPR39 in VCID in humans and animal models sets the stage for therapeutic development and other clinical applications. 

To request any disability-related accommodations for this event please contact the event coordinator at least three business days prior to the event.
Oct
27
9:00 am to 10:00 am
Wednesday, October 27, 2021 - 9:00am

AUDIENCE

Faculty
University of Arizona Health Sciences

LOCATION

Tucson area
Main Campus – Tucson
Health Sciences Innovation Building
HSIB Forum
1670 E Drachman St. Tucson, AZ

CONTACT

Mauro Oliveros
College of Medicine – Tucson
Neurosurgery